Vertex to meet with NHS England to discuss Orkambi

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said it expects to meet with NHS England next week to discuss Orkambi ivacaftor/lumacaftor following its receipt of a letter from the U.K. Department of Health urging the company to proceed with reimbursement negotiations for the cystic fibrosis drug.

The company did not disclose the specific date of the meeting...